Episode 353: 252. 2.4 Million to Prevent 4 Hospitalizations!
Packer M et al. Tirzepatide for heart failure with preserved ejection fraction and obesity. N Engl J Med 2024 Nov 16; [e-pub].https://doi.org/10.1056/NEJMoa2410027 In the industry-funded SUMMIT trial...
13 Joulu 202411min
Episode 352: 251. Safety of Triptans in Patients Who Have or Are at High Risk for Cardiovascular Disease
Wang Z et al. Safety of triptans in patients who have or are at high risk for cardiovascular disease: A target trial emulation. Mayo Clin Proc 2024 Nov; 99:1722. (https://doi.org/10.1016/j.mayocp.2024...
12 Joulu 20246min
Episode 351: 250. STROKE part 3 CME
STROKE part 3 CME
29 Marras 20249min
Episode 350: 249. STROKE - LA closure, alteplase vs tenecteplase, and thrombectomy
CME FOR FREEE
27 Marras 202417min
Episode 349: 248. Stroke- UIA, CHAD-VASC, HAS-BLED, SPARC, PFO
CME --- Stroke- UIA, CHAD-VASC, HAS-BLED, SPARC, PFO
26 Marras 202436min
Episode 348: 247. Early diagnostic paracentesis improves outcomes of hospitalized patients with cirrhosis and ascites
Beran A et al. Early diagnostic paracentesis improves outcomes of hospitalized patients with cirrhosis and ascites: A systematic review and meta-analysis. Am J Gastroenterol 2024 Nov; 119:2259. (https...
22 Marras 20246min
Episode 347: 246. Acupuncture vs Sham Acupuncture for Chronic Sciatica From Herniated Disk
Acupuncture vs Sham Acupuncture for Chronic Sciatica From Herniated Disk: A Randomized Clinical Trial | Complementary and Alternative Medicine | JAMA Internal Medicine | JAMA Network In a randomized ...
21 Marras 20248min
Episode 346: 245. Duration of benefit and risk of dual antiplatelet therapy after mild ischemic stroke
And now a secondary analysis of the trial focused on the timing of major ischemic events and the potential tradeoffs of benefits and risks,------ maybe there is magic sauce where the benefit is drasti...
20 Marras 20247min
